TIVc_LOT A + TIVc_LOT B + TIVc_LOT C + TIVf
Phase 3Completed 0 watching 0 views this week📈 Rising
77
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Prophylaxis: Influenza
Conditions
Prophylaxis: Influenza
Trial Timeline
Sep 1, 2014 → Dec 1, 2014
NCT ID
NCT02256488About TIVc_LOT A + TIVc_LOT B + TIVc_LOT C + TIVf
TIVc_LOT A + TIVc_LOT B + TIVc_LOT C + TIVf is a phase 3 stage product being developed by Novartis for Prophylaxis: Influenza. The current trial status is completed. This product is registered under clinical trial identifier NCT02256488. Target conditions include Prophylaxis: Influenza.
Hype Score Breakdown
Clinical
27
Activity
18
Company
10
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02256488 | Phase 3 | Completed |